Longterm Effect of Delaying Combination Therapy with Tumor Necrosis Factor Inhibitor in Patients with Aggressive Early Rheumatoid Arthritis: 10-year Efficacy and Safety of Adalimumab from the Randomized Controlled PREMIER Trial with Open-label Extension

Keystone, E.C.; Breedveld, F.C.; Heijde, D. van der; Landewe, R.; Florentinus, S.; Arulmani, U.; ... ; Kavanaugh, A. (2014)

Article / Letter to editor

• ADALIMUMAB
• RHEUMATOID ARTHRITIS
• LONGTERM TREATMENT RADIOGRAPHIC PROGRESSION
• SAFETY

• All authors: Keystone, E.C.; Breedveld, F.C.; Heijde, D. van der; Landewe, R.; Florentinus, S.; Arulmani, U.; Liu, S.F.; Kupper, H.; Kavanaugh, A.
• Date: 2014-01-31
• Journal: Journal of Rheumatology
• Volume: 41
• Issue: 1
• Pages: 5 - 14
• DOI: doi:10.3899/jrheum.130543